Whan In Pharm Statistics
Total Valuation
Whan In Pharm has a market cap or net worth of KRW 160.15 billion. The enterprise value is 115.08 billion.
Market Cap | 160.15B |
Enterprise Value | 115.08B |
Important Dates
The next estimated earnings date is Thursday, November 13, 2025.
Earnings Date | Nov 13, 2025 |
Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
Whan In Pharm has 15.27 million shares outstanding.
Current Share Class | 15.27M |
Shares Outstanding | 15.27M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 28.36% |
Owned by Institutions (%) | 15.08% |
Float | 10.94M |
Valuation Ratios
The trailing PE ratio is 9.76 and the forward PE ratio is 6.66.
PE Ratio | 9.76 |
Forward PE | 6.66 |
PS Ratio | 0.62 |
PB Ratio | 0.42 |
P/TBV Ratio | 0.43 |
P/FCF Ratio | 19.08 |
P/OCF Ratio | 10.86 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.74, with an EV/FCF ratio of 13.71.
EV / Earnings | 7.01 |
EV / Sales | 0.44 |
EV / EBITDA | 4.74 |
EV / EBIT | 7.86 |
EV / FCF | 13.71 |
Financial Position
The company has a current ratio of 4.91, with a Debt / Equity ratio of 0.00.
Current Ratio | 4.91 |
Quick Ratio | 2.80 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.04 |
Debt / FCF | 0.10 |
Interest Coverage | 553.75 |
Financial Efficiency
Return on equity (ROE) is 4.38% and return on invested capital (ROIC) is 2.36%.
Return on Equity (ROE) | 4.38% |
Return on Assets (ROA) | 2.08% |
Return on Invested Capital (ROIC) | 2.36% |
Return on Capital Employed (ROCE) | 3.66% |
Revenue Per Employee | 427.61M |
Profits Per Employee | 27.12M |
Employee Count | 605 |
Asset Turnover | 0.61 |
Inventory Turnover | 2.24 |
Taxes
In the past 12 months, Whan In Pharm has paid 849.69 million in taxes.
Income Tax | 849.69M |
Effective Tax Rate | 4.92% |
Stock Price Statistics
The stock price has decreased by -20.65% in the last 52 weeks. The beta is 0.28, so Whan In Pharm's price volatility has been lower than the market average.
Beta (5Y) | 0.28 |
52-Week Price Change | -20.65% |
50-Day Moving Average | 11,873.60 |
200-Day Moving Average | 11,758.65 |
Relative Strength Index (RSI) | 27.33 |
Average Volume (20 Days) | 47,043 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Whan In Pharm had revenue of KRW 258.70 billion and earned 16.41 billion in profits. Earnings per share was 1,074.45.
Revenue | 258.70B |
Gross Profit | 85.60B |
Operating Income | 14.18B |
Pretax Income | 17.26B |
Net Income | 16.41B |
EBITDA | 23.81B |
EBIT | 14.18B |
Earnings Per Share (EPS) | 1,074.45 |
Balance Sheet
The company has 45.95 billion in cash and 872.93 million in debt, giving a net cash position of 45.07 billion or 2,952.40 per share.
Cash & Cash Equivalents | 45.95B |
Total Debt | 872.93M |
Net Cash | 45.07B |
Net Cash Per Share | 2,952.40 |
Equity (Book Value) | 380.48B |
Book Value Per Share | 24,921.78 |
Working Capital | 163.36B |
Cash Flow
In the last 12 months, operating cash flow was 14.74 billion and capital expenditures -6.35 billion, giving a free cash flow of 8.39 billion.
Operating Cash Flow | 14.74B |
Capital Expenditures | -6.35B |
Free Cash Flow | 8.39B |
FCF Per Share | 549.87 |
Margins
Gross margin is 33.09%, with operating and profit margins of 5.48% and 6.34%.
Gross Margin | 33.09% |
Operating Margin | 5.48% |
Pretax Margin | 6.67% |
Profit Margin | 6.34% |
EBITDA Margin | 9.20% |
EBIT Margin | 5.48% |
FCF Margin | 3.25% |
Dividends & Yields
This stock pays an annual dividend of 300.00, which amounts to a dividend yield of 2.86%.
Dividend Per Share | 300.00 |
Dividend Yield | 2.86% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 27.91% |
Buyback Yield | n/a |
Shareholder Yield | 2.86% |
Earnings Yield | 10.25% |
FCF Yield | 5.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
The last stock split was on April 14, 2010. It was a forward split with a ratio of 2.
Last Split Date | Apr 14, 2010 |
Split Type | Forward |
Split Ratio | 2 |
Scores
Whan In Pharm has an Altman Z-Score of 4.68 and a Piotroski F-Score of 5.
Altman Z-Score | 4.68 |
Piotroski F-Score | 5 |